Zakowski, M.F., Ladanyi, M., Kris, M.G. and Memorial Sloan-Kettering Cancer Center Lung Cancer OncoGenome Group (2006) EGFR Mutations in Small-Cell Lung Cancers in Patients Who Have Never Smoked. New England Journal of Medicine, 355, 213-215. http://dx.doi.org/10.1056/NEJMc053610

has been cited by the following article:

• TITLE: Missing the Target?—Targeted Therapy in Small Cell Lung Cancer

  AUTHORS: Karin R. Purshouse

  KEYWORDS: Oncology, Small Cell Lung Cancer, Targeted Therapy, Drug Development

  JOURNAL NAME: Advances in Lung Cancer, Vol.3 No.3, August 22, 2014

  ABSTRACT: Small cell lung cancer [SCLC] is a devastating form of cancer, with most patients harbouring extensive disease at diagnosis and survival of less than 5% at five years. Progress in novel therapies has been limited. This specialist review explores current targeted therapy options and potential areas of development.